BRD4 and central nervous system cancer: Another study reported that BRD4 promotes glioma cell stemness via enhancing the activation of WNT/β-catenin signaling (by inducing the miR-142-5p promoter methylation, and for miR-142-5p—Wnt3a as a direct target) [200].